Mucosal immune responses to Bordetella pertussis in Gambian infants after maternal and primary vaccination: an immunological substudy of a single-centre, randomised, controlled, double-blind, phase 4 trial
The Innovative Medicines Initiative 2 Joint Undertaking, Horizon 2020, European Federation of Pharmaceutical Industries and Associations, Gates Foundation, Wellcome Trust, and BactiVac.
Authors
- Anja Saso (ORCID: https://orcid.org/0000-0001-9130-543X)
- Ebrima Kanteh
- Elishia Roberts
- Marc J. Eleveld (ORCID: https://orcid.org/0000-0001-7454-018X)
- Janeri Fröberg (ORCID: https://orcid.org/0000-0002-1487-3633)
- Aru-Kumba Baldeh
- Amadou Faal (ORCID: https://orcid.org/0000-0001-8836-9985)
- Thushan I. de Silva (ORCID: https://orcid.org/0000-0002-6498-9212)
- Martijn A. Huynen (ORCID: https://orcid.org/0000-0001-6189-5491)
- Sophie Roetynck
- Karamo Conteh
- M De Jonge
- Beate Kampmann (ORCID: https://orcid.org/0000-0002-6546-4709)
- Dimitri A. Diavatopoulos (ORCID: https://orcid.org/0000-0001-7065-7807)
- Michael Okoye
- Michelle Kumado
- Annemijn J. Arns
- Haddijatou Jobe
- Modou-Lamin Fofana
- Bram van Cranenbroek
- Fred van Opzeeland
Institutions
- University of London (GB)
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- London School of Hygiene & Tropical Medicine (GB)
- Radboud Institute for Molecular Life Sciences (NL)
- MRC Unit the Gambia (GM)
- University of Sheffield (GB)
Publication Details
- Journal
- The Lancet Microbe
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.lanmic.2025.101219
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- Wellcome Trust
- European Federation of Pharmaceutical Industries and Associations
- UK Research and Innovation
- Imperial College London
- Innovative Medicines Initiative
- Medical Research Council